Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | PLAU | P00749 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11016366 | 0.78 | PDE2A (0.36) | PDE2AALDH1A1LMNAMAPTHTT | |
| SCHEMBL6466452 | 0.71 | MRGPRX4 (0.36) | PDE2AALDH1A1LMNAMAPTHTT | |
| SCHEMBL6466449 | 0.71 | ALDH1A1 (0.34) | PDE2AALDH1A1LMNAMAPTHTT | |
| SCHEMBL10695243 | 0.69 | PDE2A (0.39) | PDE2AALDH1A1MAPTHTTSMN1; SMN2 | |
| SCHEMBL3822269 | 0.66 | PDE2A (0.50) | PDE2AALDH1A1MAPTMAPK1 | |
| SCHEMBL981089 | 0.63 | ALDH1A1 (0.46) | PDE2AALDH1A1HTTSMN1; SMN2PLAU | |
| SCHEMBL14934971 | 0.63 | ALDH1A1 (0.37) | PDE2AALDH1A1LMNAMAPTHTT | |
| SCHEMBL16139576 | 0.63 | PDE2A (0.36) | PDE2AALDH1A1LMNAHTTSMN1; SMN2 | |
| SCHEMBL22366856 | 0.61 | GABRB3 (0.44) | PDE2AALDH1A1SMN1; SMN2PLAUKDM4E | |
| SCHEMBL15850522 | 0.61 | PDE2A (0.41) | PDE2AALDH1A1SMN1; SMN2PLAUKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030216603-A1 | Method of manufacturing fluorine compounds, and a method of recovering or regenerating precursors of fluorinating agents | DAIKIN INDUSTRIES LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216603-A1 | Method of manufacturing fluorine compounds, and a method of recovering or regenerating precursors of fluorinating agents | AFF1, AFF2, AFF4 | PDE2A 3938/4885ALDH1A1 1752/4885LMNA 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.